First Line Therapy With Methotrexate (MTX) and Second Line Therapy With Fludarabine of Patients With T-Cell Large Granular Lymphocyte Leukemia (T-LGL).
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Fludarabine (Primary) ; Methotrexate (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 10 Aug 2016 Status changed from recruiting to discontinued.
- 10 Nov 2006 New trial record.